Literature DB >> 9346429

Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats.

J Aronowski1, R Strong, J C Grotta.   

Abstract

During reperfusion after ischemia, deleterious biochemical processes can be triggered that may antagonize the beneficial effects of reperfusion. Research into the understanding and treatment of reperfusion injury (RI) is an important objective in the new era of reperfusion therapy for stroke. To investigate RI, permanent and reversible unilateral middle cerebral artery/common carotid artery (MCA/CCA) occlusion (monitored by laser Doppler) of variable duration in Long-Evans (LE) and spontaneously hypertensive (SH) rats and unilateral MCA and bilateral CCA occlusion in selected LE rats was induced. In LE rats, infarct volume after 24 hours of permanent unilateral MCA/CCA occlusion was 31.1 +/- 34.6 mm3 and was only 28% of the infarct volume after 120 to 300 minutes of reversible occlusion plus 24 hours of reperfusion, indicating that 72% of the damage of ischemia/reperfusion is produced by RI. When reversible ischemia was prolonged to 480 and 1080 minutes, infarct volume was 39.6 mm3 and 16.6 mm3, respectively, being indistinguishable from the damage produced by permanent ischemia and significantly smaller than damage after 120 to 300 minutes of ischemia. Reperfusion injury was not seen in SH rats or with bilateral CCA occlusion in LE rats, in which perfusion is reduced more profoundly. Reperfusion injury was ameliorated by the protein synthesis inhibitor cycloheximide or spin-trap agent N-tert-butyl-alpha-phenylnitrone pretreatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9346429     DOI: 10.1097/00004647-199710000-00006

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  108 in total

Review 1.  Phosphorylation of mammalian cytochrome c and cytochrome c oxidase in the regulation of cell destiny: respiration, apoptosis, and human disease.

Authors:  Maik Hüttemann; Icksoo Lee; Lawrence I Grossman; Jeffrey W Doan; Thomas H Sanderson
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 2.  NADPH oxidase in stroke and cerebrovascular disease.

Authors:  Xian Nan Tang; Belinda Cairns; Jong Youl Kim; Midori A Yenari
Journal:  Neurol Res       Date:  2012-05       Impact factor: 2.448

3.  Stratification of heterogeneous diffusion MRI ischemic lesion with kurtosis imaging: evaluation of mean diffusion and kurtosis MRI mismatch in an animal model of transient focal ischemia.

Authors:  Jerry S Cheung; Enfeng Wang; Eng H Lo; Phillip Zhe Sun
Journal:  Stroke       Date:  2012-07-05       Impact factor: 7.914

4.  MRI of blood-brain barrier permeability in cerebral ischemia.

Authors:  Quan Jiang; James R Ewing; Michael Chopp
Journal:  Transl Stroke Res       Date:  2012-03       Impact factor: 6.829

5.  A peptide mimetic of tyrosine phosphatase STEP as a potential therapeutic agent for treatment of cerebral ischemic stroke.

Authors:  Ranjana Poddar; Sathyanarayanan Rajagopal; Lucas Winter; Andrea M Allan; Surojit Paul
Journal:  J Cereb Blood Flow Metab       Date:  2017-12-07       Impact factor: 6.200

6.  Alterations of oxidative stress markers and apoptosis markers in the striatum after transient focal cerebral ischemia in rats.

Authors:  S Matsuda; M Umeda; H Uchida; H Kato; Tsutomu Araki
Journal:  J Neural Transm (Vienna)       Date:  2009-02-24       Impact factor: 3.575

7.  Combination Therapy with LXW7 and Ceria Nanoparticles Protects against Acute Cerebral Ischemia/Reperfusion Injury in Rats.

Authors:  Ting Zhang; Chang-Yan Li; Jing-Jing Jia; Jie-Shan Chi; Da Zhou; Jian-Zhou Li; Xiao-Ma Liu; Jun Zhang; Li Yi
Journal:  Curr Med Sci       Date:  2018-03-15

8.  Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats.

Authors:  Miranda Brenneman; Sushil Sharma; Matthew Harting; Roger Strong; Charles S Cox; Jarek Aronowski; James C Grotta; Sean I Savitz
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-23       Impact factor: 6.200

9.  Antioxidant CR-6 protects against reperfusion injury after a transient episode of focal brain ischemia in rats.

Authors:  Fernando J Pérez-Asensio; Xavier de la Rosa; Francesc Jiménez-Altayó; Roser Gorina; Emili Martínez; Angel Messeguer; Elisabet Vila; Angel Chamorro; Anna M Planas
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-11       Impact factor: 6.200

10.  70th Birthday symposium of Prof. Dr. Riederer: autologous adult stem cells in ischemic and traumatic CNS disorders.

Authors:  Johannes P J M de Munter; Erik Ch Wolters
Journal:  J Neural Transm (Vienna)       Date:  2012-07-29       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.